✦ LIBER ✦

Analysis of orphan drug designations and approvals in the united states and the European union

✍ Scribed by Almutairi, R.D.; Alghamdi, A.A.; Felemban, D.F.; Seoane-Vazquez, E.; Rodriguez-Monguio, R.; Szeinbach, S.L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictors of orphan drug approval in th

✍ Harald E. Heemstra; Remco L. de Vrueh; Sonja van Weely; Hans A. Büller; Hubert G 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 158 KB

Pharmaceutical Biotechnology (Drug Disco

✍ Kayser, Oliver; Warzecha, Heribert 📂 Article 📅 2012 🏛 Wiley-VCH Verlag GmbH & Co. KGaA ⚖ 91 KB

HP1 ANALYSIS OF THE ORPHAN DRUG DESIGNAT

✍ E Seoane-Vazquez; R Rodriguez-Monguio 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

A cross-national comparative study of or

✍ Liu, Bao-cheng; He, Lin; He, Guang; He, Yun 📂 Article 📅 2010 🏛 Palgrave Publishers Ltd. 🌐 English ⚖ 95 KB

Drug evaluation and approval process in

✍ San Miguel, M. Teresa ;Vargas, Emilio 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB 👁 2 views

A comparison of cancer drug approval bet

✍ K. Redmond 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 193 KB